After many years of success, EvidenceNetwork.ca is no longer in operation. We would like to thank everyone who has contributed to the organization over the past decade including our dedicated researchers, newspaper editors, readers and funders. However, now it is time to move onto new ways of looking at knowledge mobilization and policy. Should you have any questions, please feel free to contact Shannon Sampert at s.sampert@uwinnipeg.ca.

Medical students lobby Parliament Hill for upstream solutions to the opioid crisis

A call to the emergency room announced that the ambulance was on its way. Joey, a middle-aged oilfield worker, was experiencing a suspected toxic ingestion of the opioid, fentanyl.

Canada needs a comprehensive strategy to improve prescription drug safety for seniors

Four years ago, at age 84, my dad survived a severe stroke. The downside is that during his hospital stay this otherwise fit person was put on a drug regimen and has been taking nine prescription drugs a day ever since.

Opioid crisis should be top of federal health agenda

Hundreds of codeine tablets stolen from the medicine cabinet of an elderly person living alone in a rural community. Hydromorphone tablets being distributed at weddings and high school parties. Fentanyl patches being cut up and sold for a profit on the street. This is the reality of the opioid crisis in Canada today

Le gaspillage induit par les régimes privés d’assurance-médicaments coûte plus de 5 milliards de dollars par année aux entreprises canadiennes

“Le gaspillage induit par les régimes privés d’assurance-médicaments coûte plus de 5 milliards de dollars par année aux entreprises canadiennes.” Le Dr. Marc-André Gagnon, est professeur adjoint à la School of Public Policy and Administration de l’Université Carleton.   Lisez l’article: L’inefficacité de l’assurance-médicaments privée coûte 5 milliards de dollars chaque année aux entreprises  TÉLÉCHARGEZ L’AFFICHE HAUTE-RÉSOLUTION Affiches […]

L’inefficacité de l’assurance-médicaments privée coûte 5 milliards chaque année aux entreprises

Il existe beaucoup de gaspillage au sein des systèmes de santé, mais un aspect qui semble avoir échappé à cette analyse est le gaspillage dans les assurances-médicaments privées au Canada. Estimés à plus de 5 milliards par année, cela représente la moitié des dépenses annuelles des prescriptions payées par les assureurs privés canadiens.